n-methylpyrrolidone has been researched along with lactic acid in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (4.55) | 18.2507 |
| 2000's | 7 (31.82) | 29.6817 |
| 2010's | 14 (63.64) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brodbeck, KJ; DesNoyer, JR; McHugh, AJ | 1 |
| Kleiner, L; Venkatraman, S; Wang, L | 1 |
| Bodmeier, R; Kranz, H | 1 |
| Liang, ZH; Wang, SH; Zeng, S | 1 |
| Cusella-De Angelis, MG; d'Aquino, R; De Rosa, A; Graziano, A; Laino, G; Pacifici, M; Papaccio, G; Piattelli, A | 1 |
| Cui, Y; He, HB; Lu, YX; Tang, X | 1 |
| Kempe, S; Mäder, K; Metz, H | 1 |
| Emami, SH; Karbasi, S; Mirzadeh, H; Mobedi, H; Rafienia, M | 1 |
| Azar, N; Babin, BM; Exner, AA; Mach, J; Patel, RB; Solorio, L | 1 |
| Jung, RE; Jurisic, M; Kokovic, V; Subramani, K; Weber, FE; Yaman, D | 1 |
| Li, Y; Liu, X; Sun, F; Wang, A; Wang, D; Wang, L; Zhao, X | 1 |
| Drosse, I; Friess, W; Leicht, U; Marschall, V; Schaubhut, F; Schieker, M; Schloegl, W; Volkmer, E; Wiggenhorn, M; Witting, MY; Zahler, S | 1 |
| Ahmed, TA; Hussain, MD; Ibrahim, HM; Kaseem, AA; Nutan, MT; Rahman, Z; Samy, AM | 1 |
| Luo, R; Neu, B; Venkatraman, SS | 1 |
| Boudier, A; Dupuis, F; Lartaud, I; Leroy, P; Maincent, P; Nouvel, C; Parent, M; Sapin, A; Six, JL | 1 |
| Ahmed, TA; Hussain, MD; Ibrahim, HM; Kaseem, A; Nutan, MT; Samy, AM | 1 |
| Ghayor, C; Gjoksi, B; Karfeld-Sulzer, LS; Pohjonen, TH; Siegenthaler, B; Weber, FE | 1 |
| Feng, Y; Lin, X; Shen, L; Shi, X; Zheng, X | 1 |
| Jensen, H; Larsen, SW; Petersen, NJ; Sun, Y; Østergaard, J | 2 |
| Feng, Y; Lin, X; Shen, L; Wang, L; Wu, F; Zheng, X | 1 |
| Bode, C; Kranz, H; Siepmann, F; Siepmann, J | 1 |
22 other study(ies) available for n-methylpyrrolidone and lactic acid
| Article | Year |
|---|---|
Phase inversion dynamics of PLGA solutions related to drug delivery. Part II. The role of solution thermodynamics and bath-side mass transfer.
Topics: Absorption; Benzoates; Biocompatible Materials; Chemical Precipitation; Diffusion; Drug Delivery Systems; Gels; Lactic Acid; Microscopy, Electron, Scanning; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Proteins; Pyrrolidinones; Solubility; Solutions; Solvents; Thermodynamics; Time Factors; Triacetin | 1999 |
Structure formation in injectable poly(lactide-co-glycolide) depots.
Topics: Benzoates; Calorimetry, Differential Scanning; Chemistry, Pharmaceutical; Chromatography, Gel; Delayed-Action Preparations; Drug Carriers; Drug Compounding; Drug Stability; Drug Storage; Injections; Lactic Acid; Metoclopramide; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Pyrrolidinones; Rheology; Solvents; Structure-Activity Relationship; Temperature; Time Factors | 2003 |
A novel in situ forming drug delivery system for controlled parenteral drug delivery.
Topics: Buserelin; Chemistry, Pharmaceutical; Delayed-Action Preparations; Diltiazem; Dimethyl Sulfoxide; Drug Carriers; Drug Compounding; Drug Delivery Systems; Drug Implants; Emulsions; Kinetics; Lactic Acid; Models, Chemical; Molecular Weight; Particle Size; Pharmaceutical Solutions; Polyesters; Polyglactin 910; Polymers; Porosity; Pyrrolidinones; Solubility; Solvents; Technology, Pharmaceutical | 2007 |
Monitoring release of ketoprofen enantiomers from biodegradable poly(D,L-lactide-co-glycolide) injectable implants.
Topics: Absorbable Implants; Anti-Inflammatory Agents, Non-Steroidal; Buffers; Calibration; Chemistry, Pharmaceutical; Chromatography, High Pressure Liquid; Drug Compounding; Drug Implants; Hydrogen-Ion Concentration; Injections; Ketoprofen; Lactic Acid; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Pyrrolidinones; Reproducibility of Results; Solubility; Solvents; Stereoisomerism; Time Factors | 2007 |
Concave pit-containing scaffold surfaces improve stem cell-derived osteoblast performance and lead to significant bone tissue formation.
Topics: Adult; Animals; Cells, Cultured; Enzyme-Linked Immunosorbent Assay; Fluorescent Antibody Technique; Humans; Immunocompromised Host; Immunoenzyme Techniques; Lactic Acid; Middle Aged; Osteoblasts; Osteogenesis; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Pyrrolidinones; Rats; Rats, Wistar; Stem Cells; Stromal Cells; Tissue Engineering; Tissue Scaffolds; Vascular Endothelial Growth Factor A; Young Adult | 2007 |
[Rheological properties of sucrose acetate isobutyrate in situ gel].
Topics: Antipsychotic Agents; Delayed-Action Preparations; Drug Carriers; Ethanol; Lactates; Lactic Acid; Polyesters; Polymers; Pyrrolidinones; Rheology; Risperidone; Solvents; Sucrose; Temperature; Viscosity | 2007 |
Do in situ forming PLG/NMP implants behave similar in vitro and in vivo? A non-invasive and quantitative EPR investigation on the mechanisms of the implant formation process.
Topics: Absorbable Implants; Animals; Cyclic N-Oxides; Drug Delivery Systems; Drug Implants; Electron Spin Resonance Spectroscopy; Female; Implants, Experimental; Injections, Subcutaneous; Lactic Acid; Mice; Mice, Inbred BALB C; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Pyrrolidinones; Solvents; Spin Labels; Water | 2008 |
Influence of poly (lactide-co-glycolide) type and gamma irradiation on the betamethasone acetate release from the in situ forming systems.
Topics: Betamethasone; Biological Availability; Calorimetry, Differential Scanning; Drug Implants; Gamma Rays; Heptanoates; Lactic Acid; Microscopy, Electron, Scanning; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Porosity; Pyrrolidinones; Surface Properties; Thermogravimetry | 2009 |
Noninvasive characterization of in situ forming implants using diagnostic ultrasound.
Topics: Animals; Drug Implants; Fluorescein; Lactic Acid; Male; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Pyrrolidinones; Rats; Sepharose; Ultrasonography | 2010 |
Guided bone regeneration with a synthetic biodegradable membrane: a comparative study in dogs.
Topics: Absorbable Implants; Alveolar Ridge Augmentation; Animals; Biocompatible Materials; Bone Matrix; Bone Regeneration; Bone Substitutes; Cattle; Collagen; Dental Implantation, Endosseous; Dogs; Guided Tissue Regeneration, Periodontal; Lactic Acid; Mandible; Membranes, Artificial; Minerals; Osseointegration; Osteogenesis; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Pyrrolidinones; Random Allocation; Time Factors; Tooth Extraction; Tooth Socket; Treatment Outcome | 2011 |
Design of a long-term antipsychotic in situ forming implant and its release control method and mechanism.
Topics: Animals; Antipsychotic Agents; Delayed-Action Preparations; Dimethyl Sulfoxide; Dizocilpine Maleate; Dogs; Drug Implants; Excipients; Excitatory Amino Acid Antagonists; Gels; Isoxazoles; Kinetics; Lactic Acid; Male; Mice; Microscopy, Electron, Scanning; Microspheres; Paliperidone Palmitate; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Pyrimidines; Pyrrolidinones; Solubility; Solutions; Solvents; Stereotyped Behavior | 2012 |
Porosity and mechanically optimized PLGA based in situ hardening systems.
Topics: Biocompatible Materials; Bone Substitutes; Calcium Phosphates; Carboxymethylcellulose Sodium; Cell Survival; Cells, Cultured; Dimethyl Sulfoxide; Humans; Lactic Acid; Polyethylene Glycols; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Porosity; Pyrrolidinones; Solvents; Tissue Scaffolds | 2012 |
Development of meloxicam in situ implant formulation by quality by design principle.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Area Under Curve; Chemistry, Pharmaceutical; Drug Carriers; Drug Compounding; Drug Implants; Gels; Inhibitory Concentration 50; Lactic Acid; Male; Meloxicam; Microscopy, Electron, Scanning; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Pyrrolidinones; Rats; Rats, Sprague-Dawley; Spectroscopy, Fourier Transform Infrared; Thiazines; Thiazoles; Viscosity; X-Ray Diffraction | 2014 |
Layer-by-layer polyelectrolyte-polyester hybrid microcapsules for encapsulation and delivery of hydrophobic drugs.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Calcium Carbonate; Capsules; Drug Carriers; Electrolytes; Hydrophobic and Hydrophilic Interactions; Ibuprofen; Lactic Acid; Magnetite Nanoparticles; Particle Size; Polyamines; Polyesters; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polystyrenes; Pyrrolidinones | 2013 |
Are in situ formulations the keys for the therapeutic future of S-nitrosothiols?
Topics: Animals; Arterial Pressure; Chemistry, Pharmaceutical; Delayed-Action Preparations; Drug Carriers; Drug Delivery Systems; Drug Implants; Hydrophobic and Hydrophilic Interactions; Lactic Acid; Male; Microspheres; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Pyrrolidinones; Rats; Rats, Wistar; S-Nitroso-N-Acetylpenicillamine; S-Nitrosoglutathione; Telemetry; Triacetin; Vasodilation; Vasodilator Agents | 2013 |
Biodegradable injectable in situ implants and microparticles for sustained release of montelukast: in vitro release, pharmacokinetics, and stability.
Topics: Absorbable Implants; Acetates; Animals; Chemistry, Pharmaceutical; Cyclopropanes; Dimethyl Sulfoxide; Drug Implants; Drug Stability; Injections, Intramuscular; Lactic Acid; Leukotriene Antagonists; Male; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Pyrrolidinones; Quinolines; Rats, Sprague-Dawley; Solubility; Solvents; Sulfides; Technology, Pharmaceutical; Temperature; Triacetin | 2014 |
Comparative study of NMP-preloaded and dip-loaded membranes for guided bone regeneration of rabbit cranial defects.
Topics: Absorbable Implants; Animals; Biocompatible Materials; Bone Regeneration; Bone Substitutes; Guided Tissue Regeneration; Lactic Acid; Membranes, Artificial; Microscopy, Electron, Scanning; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Pyrrolidinones; Rabbits | 2017 |
Injectable long-acting systems for Radix Ophiopogonis polysaccharide based on mono-PEGylation and in situ formation of a PLGA depot.
Topics: Animals; Delayed-Action Preparations; Drugs, Chinese Herbal; Fructans; Injections, Subcutaneous; Lactic Acid; Male; Ophiopogon; Polyethylene Glycols; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Pyrrolidinones; Rats; Rats, Sprague-Dawley; Viscosity | 2014 |
Phase separation of in situ forming poly (lactide-co-glycolide acid) implants investigated using a hydrogel-based subcutaneous tissue surrogate and UV-vis imaging.
Topics: Dioxanes; Hydrogel, Polyethylene Glycol Dimethacrylate; Hydrogels; Lactic Acid; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Pyrrolidinones; Subcutaneous Tissue | 2017 |
Concomitant monitoring of implant formation and drug release of in situ forming poly (lactide-co-glycolide acid) implants in a hydrogel matrix mimicking the subcutis using UV-vis imaging.
Topics: Chemistry, Pharmaceutical; Drug Carriers; Drug Delivery Systems; Drug Implants; Drug Liberation; Hydrogels; Lactalbumin; Lactic Acid; Piroxicam; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Pyrrolidinones; Spectrophotometry, Ultraviolet; Spectrum Analysis; Subcutaneous Tissue; Triacetin | 2018 |
Delivery of radix ophiopogonis polysaccharide via sucrose acetateisobutyrate-based in situ forming systems alone or combined with itsmono-PEGylation.
Topics: Animals; Delayed-Action Preparations; Drug Carriers; Drug Delivery Systems; Drugs, Chinese Herbal; Lactic Acid; Male; Plant Roots; Polyesters; Polyethylene Glycols; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polysaccharides; Pyrrolidinones; Rats; Rats, Sprague-Dawley; Sucrose | 2018 |
In-situ forming PLGA implants for intraocular dexamethasone delivery.
Topics: Anti-Inflammatory Agents; Dexamethasone; Drug Implants; Drug Liberation; Lactic Acid; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Pyrrolidinones | 2018 |